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Pakistan is 6th largest country with over 180 million population. Overall life expectancy has increased from an average of 45–66 in last 70 years [1]. Annual per capita health
expenditure is 39 $, which is comparatively lower than other
developing countries [2]. Consanguineous marriages have
affected a great number of population in terms of hereditary disorders. Thalassemia, bone marrow failure syndromes, immunodeficiency states and hemophilia are
common genetic disorders with high disease burden [3].
These diseases can be prevented otherwise by appropriate
genetic counseling. Inadequate social security system, lack
of awareness, inefficient prevention programs and deficiency of advanced diagnostics facilities, worsen the situation. Mostly of the genetic disorders are incurable and
result in disability or death. With technological advancement and research in field of hematopoietic stem cell transplantation, it is emerging as possible cure of genetic
disabilities. Establishment of transfusion facility, platelet
separation and storage methods, developments in HLA typing and acquisition of knowledge in radiotherapy, laid the
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foundation for stem cell research in Pakistan back in 1978.
Technology transfer started in 1992, when respective individuals were trained in various aspects of bone marrow
transplantation. Hematopoietic stem cell transplant (HSCT)
activity started in 1995 with auto HSCT transplant on a
patient with AML, but till 2004 only two transplant centers
were functional with less than 50 transplants per year [4].
Currently there are 8 stem cell transplant centers accredited by national statutory body. In last 2 decades, 1851
HSCT have been carried out [5]. Most of the patients
(n = 1592) were of Allogenic (allo) HSCT and others were
auto HSCT (n = 259). Primary indications for allo HSCT were
beta thalassemia (n = 603), aplastic anemia (n = 540) and
acute leukemias (n = 169). The autologous transplants were
carried out mainly for lymphomas (n = 155), multiple myeloma (n = 67) and AML (n = 19). Peripheral blood stem cells
(PBSC) were used as source of stem cells in 903 cases, it
was used as source, followed by bone marrow in 671 cases.
While for 277 cases both the PBSC and marrow infusion were
used simultaneously. Still the number of patients are few
compared to the actual burden of diseases. For the year
2016, 9 persons per 10 million population underwent HSCT.
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The field of HSCT has expanded globally with the advent of
cord blood stem cells storage and establishment of matched
unrelated donor (MUD) registries in many countries. Pakistan being a resource-constrained country lacks the infrastructure for MUD registry or cord blood banks. The
transplant activity is likely to increase due to recent developments in haplo identical HSCT. So far 35 haplo-identical
transplants have been carried out in the country with
encouraging results. With only a handful transplant centers;
the waiting list for these patients is ever growing. Moreover,
advanced health care facilities and diagnostics centers, are
confined to the three larger cities, and only a hand full of
population has access to that. Absence of registry for transplant and bone marrow donors, unavailability of cord blood
banks, expensive chemotherapeutic agents and non-availability of monoclonal antibodies, remains obstacles in
development of this newly emerging field.
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